Skip to main content
Top
Published in: Endocrine 2/2009

01-04-2009 | Original Paper

Peripheral blood leukocyte distribution and body mass index are associated with the methylation pattern of the androgen receptor promoter

Authors: Sofia Movérare-Skrtic, Dan Mellström, Liesbeth Vandenput, Mathias Ehrich, Claes Ohlsson

Published in: Endocrine | Issue 2/2009

Login to get access

Abstract

Methylation of CpG sites in the promoter region can affect gene transcription. DNA derived from peripheral blood leukocytes (PBL) from the well-characterized clinical cohorts might be useful to study the influence of environmental factors on DNA methylation. However, these studies could be confounded by the heterogeneous nature of PBL. The aims of this study were to determine the impact of PBL distribution on methylation status of the androgen receptor (AR) promoter, and determine the associations between PBL distribution-adjusted methylation status of the AR promoter and AR-related phenotypes. PBL differential count analyses were performed at the time of blood sampling for DNA preparation in 170 elderly men. The DNA was bisulfite treated, and the methylation status of five CpG units in the AR promoter was analyzed using a high-throughput technique based on MALDI-TOF mass spectrometry. The degree of methylation of all the five investigated CpG units was strongly positively associated with the percent of lymphocytes in the PBL (r s = 0.17–0.49, P < 0.05). Furthermore, the PBL distribution-adjusted methylation status of a specific CpG unit in the AR promoter was significantly associated with body mass index (r s = 0.24) and other measures reflecting fat mass in elderly men. In conclusion, adjustment for PBL distribution needs to be done to be able to use DNA from whole blood for methylation analysis of the AR promoter and most likely also when investigating other promoters.
Literature
4.
go back to reference M. Esteller, P.G. Corn, S.B. Baylin, J.G. Herman, Cancer Res. 61, 3225–3229 (2001)PubMed M. Esteller, P.G. Corn, S.B. Baylin, J.G. Herman, Cancer Res. 61, 3225–3229 (2001)PubMed
6.
go back to reference M. Ehrich, M.R. Nelson, P. Stanssens, M. Zabeau, T. Liloglou, G. Xinarianos, C.R. Cantor, J.K. Field, D. van den Boom, Proc. Natl. Acad. Sci. U.S.A. 102, 15785–15790 (2005)CrossRefPubMed M. Ehrich, M.R. Nelson, P. Stanssens, M. Zabeau, T. Liloglou, G. Xinarianos, C.R. Cantor, J.K. Field, D. van den Boom, Proc. Natl. Acad. Sci. U.S.A. 102, 15785–15790 (2005)CrossRefPubMed
7.
go back to reference A. Vottero, M. Capelletti, S. Giuliodori, I. Viani, M. Ziveri, T.M. Neri, S. Bernasconi, L. Ghizzoni, J. Clin. Endocrinol. Metab. 91, 968–972 (2006)CrossRefPubMed A. Vottero, M. Capelletti, S. Giuliodori, I. Viani, M. Ziveri, T.M. Neri, S. Bernasconi, L. Ghizzoni, J. Clin. Endocrinol. Metab. 91, 968–972 (2006)CrossRefPubMed
8.
10.
go back to reference S.A. Brechenmacher, C.J. Bruns, N.K. Van den Engel, P. Angele, F. Loehe, K.W. Jauch, M.K. Angele, Langenbecks Arch. Surg. 393, 871–876 (2008)CrossRefPubMed S.A. Brechenmacher, C.J. Bruns, N.K. Van den Engel, P. Angele, F. Loehe, K.W. Jauch, M.K. Angele, Langenbecks Arch. Surg. 393, 871–876 (2008)CrossRefPubMed
11.
go back to reference Y. Yamada, M. Toyota, Y. Hirokawa, H. Suzuki, A. Takagi, T. Matsuzaki, Y. Sugimura, R. Yatani, T. Shiraishi, M. Watanabe, Int. J. Cancer 112, 840–845 (2004)CrossRefPubMed Y. Yamada, M. Toyota, Y. Hirokawa, H. Suzuki, A. Takagi, T. Matsuzaki, Y. Sugimura, R. Yatani, T. Shiraishi, M. Watanabe, Int. J. Cancer 112, 840–845 (2004)CrossRefPubMed
12.
go back to reference M. Sasaki, Y. Tanaka, G. Perinchery, A. Dharia, I. Kotcherguina, S. Fujimoto, R. Dahiya, J. Natl. Cancer Inst. 94, 384–390 (2002)PubMed M. Sasaki, Y. Tanaka, G. Perinchery, A. Dharia, I. Kotcherguina, S. Fujimoto, R. Dahiya, J. Natl. Cancer Inst. 94, 384–390 (2002)PubMed
13.
go back to reference H. Kinoshita, Y. Shi, C. Sandefur, L.F. Meisner, C. Chang, A. Choon, C.R. Reznikoff, G.S. Bova, A. Friedl, D.F. Jarrard, Cancer Res. 60, 3623–3630 (2000)PubMed H. Kinoshita, Y. Shi, C. Sandefur, L.F. Meisner, C. Chang, A. Choon, C.R. Reznikoff, G.S. Bova, A. Friedl, D.F. Jarrard, Cancer Res. 60, 3623–3630 (2000)PubMed
15.
go back to reference L. Vandenput, D. Mellstrom, M. Lorentzon, C. Swanson, M.K. Karlsson, J. Brandberg, L. Lonn, E. Orwoll, U. Smith, F. Labrie, O. Ljunggren, A. Tivesten, C. Ohlsson, J. Clin. Endocrinol. Metab. 92, 4130–4137 (2007)CrossRefPubMed L. Vandenput, D. Mellstrom, M. Lorentzon, C. Swanson, M.K. Karlsson, J. Brandberg, L. Lonn, E. Orwoll, U. Smith, F. Labrie, O. Ljunggren, A. Tivesten, C. Ohlsson, J. Clin. Endocrinol. Metab. 92, 4130–4137 (2007)CrossRefPubMed
16.
go back to reference V.G. Daniels, P.R. Wheater, H.G. Burkitt, Functional Histology: A Text and Colour Atlas (Churchill Livingstone, Edinburgh, 1979) V.G. Daniels, P.R. Wheater, H.G. Burkitt, Functional Histology: A Text and Colour Atlas (Churchill Livingstone, Edinburgh, 1979)
17.
go back to reference D. Mellstrom, O. Johnell, O. Ljunggren, A.L. Eriksson, M. Lorentzon, H. Mallmin, A. Holmberg, I. Redlund-Johnell, E. Orwoll, C. Ohlsson, J. Bone Miner. Res. 21, 529–535 (2006)CrossRefPubMed D. Mellstrom, O. Johnell, O. Ljunggren, A.L. Eriksson, M. Lorentzon, H. Mallmin, A. Holmberg, I. Redlund-Johnell, E. Orwoll, C. Ohlsson, J. Bone Miner. Res. 21, 529–535 (2006)CrossRefPubMed
18.
go back to reference F. Labrie, A. Belanger, P. Belanger, R. Berube, C. Martel, L. Cusan, J. Gomez, B. Candas, I. Castiel, V. Chaussade, C. Deloche, J. Leclaire, J. Steroid Biochem. Mol. Biol. 99, 182–188 (2006)CrossRefPubMed F. Labrie, A. Belanger, P. Belanger, R. Berube, C. Martel, L. Cusan, J. Gomez, B. Candas, I. Castiel, V. Chaussade, C. Deloche, J. Leclaire, J. Steroid Biochem. Mol. Biol. 99, 182–188 (2006)CrossRefPubMed
19.
go back to reference L. Vandenput, F. Labrie, D. Mellstrom, C. Swanson, T. Knutsson, R. Peeker, O. Ljunggren, E. Orwoll, A.L. Eriksson, J.E. Damber, C. Ohlsson, J. Bone Miner. Res. 22, 220–227 (2007)CrossRefPubMed L. Vandenput, F. Labrie, D. Mellstrom, C. Swanson, T. Knutsson, R. Peeker, O. Ljunggren, E. Orwoll, A.L. Eriksson, J.E. Damber, C. Ohlsson, J. Bone Miner. Res. 22, 220–227 (2007)CrossRefPubMed
20.
Metadata
Title
Peripheral blood leukocyte distribution and body mass index are associated with the methylation pattern of the androgen receptor promoter
Authors
Sofia Movérare-Skrtic
Dan Mellström
Liesbeth Vandenput
Mathias Ehrich
Claes Ohlsson
Publication date
01-04-2009
Publisher
Springer US
Published in
Endocrine / Issue 2/2009
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-009-9153-7

Other articles of this Issue 2/2009

Endocrine 2/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine